Abstract:Objective: To correlate the common driver gene variations in primary lung adenocarcinoma with their clinical characteristics and histopathological subtypes. Methods: There were 4 995 cases of primary lung adenocarcinoma diagnosed at Weifang People's Hospital of Shandong Province from January 2015 to December 2021 which were retrospectively analyzed. Among them 1 983 cases were evaluated for their histopathological subtype; 3 012 were analyzed for the correlation of their histopathological subtypes and corresponding driver gene variations, including invasive non-mucinous adenocarcinoma (INMA) and invasive mucinous adenocarcinoma (IMA), and morphologically, poorly-differentiated, moderately-differentiated and well-differentiated adenocarcinomas. Next-generation sequencing was used to detect variations in EGFR, KRAS, ALK, RET, ROS1, MET, HER2, or BRAF driver genes. Results: There were 2 384 males and 2 611 females. EGFR and ALK variations were more commonly found in female patients aged 60 years or older, with EGFR mutation rate in clinical stage Ⅰ (25.80%) significantly higher than in other stages (P<0.05). KRAS mutations were more commonly detected in male smokers aged 60 years or older, HER2 mutations were more commonly in patients younger than 60 years, and RET mutations were more commonly in non-smokers (all P<0.05). No correlation was found between ROS1, MET, and BRAF gene variations and their clinical characteristics (P>0.05). For the histopathological subtypes, among the 1 899 cases of acinar adenocarcinoma, EGFR mutation rate was the highest (67.30%) compared to the other genes. Exon 21 L858R and exon 19 del were the main mutation sites in IMA and INMA, with a higher mutation rate at exon 20 T790M (11.63%) in micropapillary adenocarcinoma. In IMA, KRAS had the highest overall mutation rate (43.80%), with statistically significant difference in mutation rates of exon 2 G12D and exon 2 G12V in acinar adenocarcinoma, solid, and IMA (P<0.05). KRAS mutation at various sites were higher in poorly differentiated groups compared to moderately- and well-differentiated groups (P<0.05). HER2 mutations were more commonly observed in acinar adenocarcinoma, papillary, and micropapillary adenocarcinoma of INMA. BRAF mutation was higher in micropapillary adenocarcinoma compared with other types (P<0.05). Conclusions: Variations in EGFR, ALK, KRAS, HER2, and RET in primary lung adenocarcinoma are associated with patients' age, smoking history, and clinical stage, and driver gene mutations vary among different histopathological subtypes. EGFR mutations are predominant in INMA, while KRAS mutations are predominant in IMA.

Rare Discrepancy in Driving Gene Mutations Between Histologically Heterogeneous Primary Lung Cancer.

Correlation Analysis Between Driver Gene Mutation and Clinicopathological Features in Lung Adenocarcinoma Based on Real-World Cumulative Clinical Data

Intratumoral heterogeneity of oncogenic drivers in mixed histology lung adenocarcinomas: How tissue selection impacts molecular testing?

Comprehensive Investigation of Mutational Features of Various Lung Adenocarcinoma Histological Subtypes among Chinese Patients.

Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions

Analysis of Major Known Driver Mutations and Prognosis in Resected Adenosquamous Lung Carcinomas

[Correlation between common driver gene variations and clinicopathological typing in lung adenocarcinoma]

Mutational Distinction Between Adenocarcinoma in Situ, Minimally Invasive Adenocarcinoma and Invasive Adenocarcinoma in Lung Cancer Patients with Multiple Tumors.

Coexistence of Low-Grade Fetal Adenocarcinoma and Adenocarcinoma in Situ of the Lung Harboring Different Genetic Mutations: A Case Report and Review of Literature

Frequency of Driver Mutations in Lung Adenocarcinoma from Female Never-Smokers Varies with Histologic Subtypes and Age at Diagnosis

Comparison of gene mutation profile in different lung adenocarcinoma subtypes by targeted next-generation sequencing

Gene Status and Clinicopathologic Characteristics of Lung Adeno-Carcinomas with Mediastinal Lymph Node Metastasis

Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study

Uncommon/rare oncogenic drivers in non‐small cell lung cancer: Consensus and contention

Distinct gene mutation profiles among multiple and single primary lung adenocarcinoma

Heterogeneity Between Primary Colon Carcinoma and Paired Lymphatic and Hepatic Metastases.

Favorable prognosis and high discrepancy of genetic features in surgical patients with multiple primary lung cancers.

Comparative Analysis of Co-Occurring Mutations of Specific Tumor Suppressor Genes in Lung Adenocarcinoma Between Asian and Caucasian Populations

Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients

Genomic heterogeneity of multiple synchronous lung cancers in Chinese population

Relationship between driver gene mutations and clinical pathological characteristics in older lung adenocarcinoma